PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Evaluating the efficacy and timing of blood purification modalities in early-stage hyperlipidemic acute pancreatitis treatment, Lipids in Health and Disease
bok%3A978-1-4939-0515-7.pdf ?auth66=1397940469_51b8ba57efa3ddcad3f8aa303951bc25&ext=
Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials
Diabetic dyslipidaemia - ScienceDirect
Considerations in the Approach to Appropriate Statin Selection
Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components. - Abstract - Europe PMC
2018 Guidelines for the management of dyslipidemia
Anti-atherosclerotic therapies: Milestones, challenges, and emerging innovations: Molecular Therapy
IJMS, Free Full-Text
The Role of Coenzyme Q10 in Statin-Associated Myopathy: A Systematic Review
de
por adulto (o preço varia de acordo com o tamanho do grupo)
